-
Je něco špatně v tomto záznamu ?
Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome
A. Chowdhury, A. Boshnakovska, A. Aich, A. Methi, AM. Vergel Leon, I. Silbern, C. Lüchtenborg, L. Cyganek, J. Prochazka, R. Sedlacek, J. Lindovsky, D. Wachs, Z. Nichtova, D. Zudova, G. Koubkova, A. Fischer, H. Urlaub, B. Brügger, DM. Katschinski,...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2009
Free Medical Journals
od 2009
PubMed Central
od 2009
Europe PubMed Central
od 2009
ProQuest Central
od 2009-04-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Open Access Digital Library
od 2009-01-01
Medline Complete (EBSCOhost)
od 2011-01-01
Health & Medicine (ProQuest)
od 2009-04-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
PubMed
37533404
DOI
10.15252/emmm.202317399
Knihovny.cz E-zdroje
- MeSH
- adenosintrifosfát MeSH
- Barthův syndrom * metabolismus patologie MeSH
- glykolýza MeSH
- kardiolipiny metabolismus MeSH
- mastné kyseliny metabolismus MeSH
- myši MeSH
- proteinkinasy aktivované AMP metabolismus MeSH
- zvířata MeSH
- Check Tag
- myši MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Mitochondria are central for cellular metabolism and energy supply. Barth syndrome (BTHS) is a severe disorder, due to dysfunction of the mitochondrial cardiolipin acyl transferase tafazzin. Altered cardiolipin remodeling affects mitochondrial inner membrane organization and function of membrane proteins such as transporters and the oxidative phosphorylation (OXPHOS) system. Here, we describe a mouse model that carries a G197V exchange in tafazzin, corresponding to BTHS patients. TAZG197V mice recapitulate disease-specific pathology including cardiac dysfunction and reduced oxidative phosphorylation. We show that mutant mitochondria display defective fatty acid-driven oxidative phosphorylation due to reduced levels of carnitine palmitoyl transferases. A metabolic switch in ATP production from OXPHOS to glycolysis is apparent in mouse heart and patient iPSC cell-derived cardiomyocytes. An increase in glycolytic ATP production inactivates AMPK causing altered metabolic signaling in TAZG197V . Treatment of mutant cells with AMPK activator reestablishes fatty acid-driven OXPHOS and protects mice against cardiac dysfunction.
Czech Centre for Phenogenomics Institute of Molecular Genetics of the CAS Prague Czech Republic
Department of Cardiovascular Physiology University Medical Center Göttingen Göttingen Germany
Department of Cellular Biochemistry University Medical Center Göttingen Göttingen Germany
Department of Psychiatry and Psychotherapy University Medical Center Göttingen Göttingen Germany
DZHK partner site Göttingen Göttingen Germany
Heidelberg University Biochemistry Center Heidelberg Germany
Institute for Clinical Chemistry University Medical Center Göttingen Göttingen Germany
Max Planck Institute for Multidisciplinary Science Göttingen Germany
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23016251
- 003
- CZ-PrNML
- 005
- 20231026110104.0
- 007
- ta
- 008
- 231013s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.15252/emmm.202317399 $2 doi
- 035 __
- $a (PubMed)37533404
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Chowdhury, Arpita $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000150250268
- 245 10
- $a Metabolic switch from fatty acid oxidation to glycolysis in knock-in mouse model of Barth syndrome / $c A. Chowdhury, A. Boshnakovska, A. Aich, A. Methi, AM. Vergel Leon, I. Silbern, C. Lüchtenborg, L. Cyganek, J. Prochazka, R. Sedlacek, J. Lindovsky, D. Wachs, Z. Nichtova, D. Zudova, G. Koubkova, A. Fischer, H. Urlaub, B. Brügger, DM. Katschinski, J. Dudek, P. Rehling
- 520 9_
- $a Mitochondria are central for cellular metabolism and energy supply. Barth syndrome (BTHS) is a severe disorder, due to dysfunction of the mitochondrial cardiolipin acyl transferase tafazzin. Altered cardiolipin remodeling affects mitochondrial inner membrane organization and function of membrane proteins such as transporters and the oxidative phosphorylation (OXPHOS) system. Here, we describe a mouse model that carries a G197V exchange in tafazzin, corresponding to BTHS patients. TAZG197V mice recapitulate disease-specific pathology including cardiac dysfunction and reduced oxidative phosphorylation. We show that mutant mitochondria display defective fatty acid-driven oxidative phosphorylation due to reduced levels of carnitine palmitoyl transferases. A metabolic switch in ATP production from OXPHOS to glycolysis is apparent in mouse heart and patient iPSC cell-derived cardiomyocytes. An increase in glycolytic ATP production inactivates AMPK causing altered metabolic signaling in TAZG197V . Treatment of mutant cells with AMPK activator reestablishes fatty acid-driven OXPHOS and protects mice against cardiac dysfunction.
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a Barthův syndrom $x metabolismus $x patologie $7 D056889
- 650 _2
- $a kardiolipiny $x metabolismus $7 D002308
- 650 _2
- $a proteinkinasy aktivované AMP $x metabolismus $7 D055372
- 650 _2
- $a glykolýza $7 D006019
- 650 _2
- $a mastné kyseliny $x metabolismus $7 D005227
- 650 _2
- $a adenosintrifosfát $7 D000255
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Boshnakovska, Angela $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0009000835720223
- 700 1_
- $a Aich, Abhishek $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany $u Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany
- 700 1_
- $a Methi, Aditi $u Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany $u Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
- 700 1_
- $a Vergel Leon, Ana Maria $u Department of Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany
- 700 1_
- $a Silbern, Ivan $u The Bioanalytical Mass Spectrometry Group, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany $u Institute for Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/000000018284954X
- 700 1_
- $a Lüchtenborg, Christian $u Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany
- 700 1_
- $a Cyganek, Lukas $u Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany $u DZHK (German Center for Cardiovascular Research) partner site Göttingen, Göttingen, Germany $u Stem Cell Unit, Clinic for Cardiology and Pneumology, University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany
- 700 1_
- $a Prochazka, Jan $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic $1 https://orcid.org/0000000346758995
- 700 1_
- $a Sedlacek, Radislav $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic
- 700 1_
- $a Lindovsky, Jiri $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic
- 700 1_
- $a Wachs, Dominic $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
- 700 1_
- $a Nichtova, Zuzana $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic
- 700 1_
- $a Zudova, Dagmar $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic
- 700 1_
- $a Koubkova, Gizela $u Czech Centre for Phenogenomics, Institute of Molecular Genetics of the CAS, Prague, Czech Republic
- 700 1_
- $a Fischer, André $u Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany $u Department of Psychiatry and Psychotherapy, University Medical Center Göttingen, Göttingen, Germany $u Department for Epigenetics and Systems Medicine in Neurodegenerative Diseases, German Center for Neurodegenerative Diseases (DZNE), Göttingen, Germany
- 700 1_
- $a Urlaub, Henning $u The Bioanalytical Mass Spectrometry Group, Max Planck Institute for Multidisciplinary Sciences, Göttingen, Germany $u Institute for Clinical Chemistry, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000318375233
- 700 1_
- $a Brügger, Britta $u Heidelberg University Biochemistry Center (BZH), Heidelberg, Germany
- 700 1_
- $a Katschinski, Dörthe M $u Department of Cardiovascular Physiology, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000346309081
- 700 1_
- $a Dudek, Jan $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany
- 700 1_
- $a Rehling, Peter $u Department of Cellular Biochemistry, University Medical Center Göttingen, Göttingen, Germany $u Cluster of Excellence "Multiscale Bioimaging: from Molecular Machines to Networks of Excitable Cells" (MBExC), University of Göttingen, Göttingen, Germany $u Max Planck Institute for Multidisciplinary Science, Göttingen, Germany $1 https://orcid.org/0000000156615272
- 773 0_
- $w MED00189522 $t EMBO molecular medicine $x 1757-4684 $g Roč. 15, č. 9 (2023), s. e17399
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37533404 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20231013 $b ABA008
- 991 __
- $a 20231026110059 $b ABA008
- 999 __
- $a ok $b bmc $g 2000020 $s 1202613
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 15 $c 9 $d e17399 $e 20230803 $i 1757-4684 $m EMBO molecular medicine $n EMBO Mol Med $x MED00189522
- LZP __
- $a Pubmed-20231013